Cubist pharmaceuticals stock price

Author: lluw

August undefined, 2024

WebCubist Pharmaceuticals Stock Price, Funding, Valuation, Revenue & Financial Statements Cubist Pharmaceuticals Unclaimed cubist.com Claim your profile to get in front of buyers, investors, and analysts. Submit Your Analyst Briefing Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Learn more. Overview & … WebFind the latest 467037 (CBST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Trius Therapeutics To Be Acquired By Cubist - SeekingAlpha

WebApr 14, 2024 · RadNet, Inc. (NASDAQ:RDNT – Get Rating)’s share price reached a new 52-week high on Wednesday . The stock traded as high as $27.59 and last traded at $27.35, with a volume of 15491 shares ... WebSep 5, 2013 · Cubist Pharmaceuticals, Inc. today announced the pricing of $700 million aggregate principal amount of convertible senior unsecured notes that will be issued in … optical tag

CUBIST PHARMACEUTICALS INC : Stock Price

WebApr 11, 2024 · Cubist Systematic Strategies LLC now owns 40,323 shares of the biotechnology company’s stock valued at $2,092,000 after buying an additional 2,900 shares during the last quarter. Prudential... WebApr 10, 2024 · According to analysts' consensus price target of $45.17, Ionis Pharmaceuticals has a forecasted upside of 22.8% from its current price of $36.79. Amount of Analyst Coverage Ionis Pharmaceuticals has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. See Top … WebJan 21, 2015 · outstanding shares of common stock of Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) at a purchase price of $102.00 per share. As of the tender offer … portland cement and perlite

Clinical Study Updates, Collaborations, and Stock Price Updates ...

Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash

WebMar 7, 2011 · Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that its Board of Directors has appointed Kenneth M. (Ken) Bate as non-executive Chair of the Board effective immediately. Mr. Bate has been serving as Lead Director of the Cubist Board since June of 2006. Cubist has had a long-standing commitment to the clear … WebApr 14, 2024 · FaZe Holdings Inc. ( NASDAQ:FAZE – Get Rating )’s stock price shot up 6.3% on Thursday . The company traded as high as $0.52 and last traded at $0.51. 384,459 shares changed hands during ... portland cc bookstoreWebExhibit 10.1 . CUBIST PHARMACEUTICALS, INC. 2014 OMNIBUS INCENTIVE PLAN . STOCK OPTION AGREEMENT. FOR DIRECTORS . This Stock Option Agreement (the “Agreement”) governs an award (the “Award”) of stock options (“Stock Options”) to non-employee members of the Board of Directors of Cubist Pharmaceuticals, Inc. (the … portland cement and sand mix for pavers

"WebApr 12, 2024 · Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Rating)’s stock price traded up 6.3% during mid-day trading on Tuesday after Piper Sandler raised their price target on the stock from $49.00 ... " - Cubist pharmaceuticals stock price

Cubist pharmaceuticals stock price

Kiniksa Pharmaceuticals - KNSA Stock Forecast, Price & News

WebDec 8, 2014 · Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash Business Wire Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash Acquisition Augments Merck’s Strong... WebApr 6, 2024 · 14 brokers have issued 1 year price objectives for Apellis Pharmaceuticals' shares. Their APLS share price forecasts range from $40.00 to $139.00. On average, they predict the company's share price to reach $78.40 in the next twelve months. This suggests that the stock has a possible downside of 0.5%.

Did you know?

WebDec 31, 2013 · On December 26, 2013, Cubist Pharmaceuticals Inc.'s (Cubist) stock declined 0.39%, ending the day's trading session at $66.94. Over the previous three trading sessions, shares of Cubist... WebJan 9, 2015 · Cubist Pharmaceuticals shoots to the moon after a big pharma rival agreed to purchase it for a hefty premium. Why Cubist Pharmaceuticals Inc. Stock …

WebApr 9, 2024 · The stock was sold at an average price of $4.83, for a total value of $172,498.62. Following the transaction, the director now owns 783,965 shares in the company, valued at approximately ... WebJul 14, 2024 · Cubist Pharmaceuticals Inc (NASDAQ:CBST) issued its earnings results on Tuesday, October, 21st. The biopharmaceutical company reported $0.58 earnings per … Their NVAX share price forecasts range from $27.00 to $168.00. On average, … What is Intercept Pharmaceuticals' stock price forecast for 2024? 7 equities … The current CBST price target is $0.00. Learn why top analysts are making this …

WebApr 12, 2024 · Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Rating) shot up 6.3% on Tuesday after Piper Sandler raised their price target on the stock from $49.00 to $54.00. Piper Sandler currently has ... WebDec 8, 2014 · NEW YORK -- Shares of Cubist Pharmaceuticals are up 36.01% to $101.14 in pre-market trade after it was reported that Merck & Co.

WebApr 11, 2024 · 3 Wall Street research analysts have issued 1-year price objectives for Amphastar Pharmaceuticals' shares. Their AMPH share price forecasts range from $36.00 to $44.00. On average, they predict the company's share price to reach $40.75 in the next year. This suggests a possible upside of 3.2% from the stock's current price.

WebNumber of Exits 1. Phone Number +8589090737. Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. It has two late-stage anti-infective product candidates, fidaxomicin and Pruvel (prulifloxacin). Optimer's development efforts are focused on products ... portland cement assoWebJan 21, 2015 · Merck announced the successful completion of the tender offer for all of the outstanding shares of common stock of Cubist Pharmaceuticals, Inc. at a purchase … portland cement and lime mixWebCubist Pharmaceuticals Inc. share price - Stocktwits is the best way to find out what is happening right now around the CBST stock and other stock companies and markets. optical tarbesWebApr 9, 2024 · Cantor Fitzgerald upped their target price on shares of ACADIA Pharmaceuticals from $28.00 to $33.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 14th. portland cement bag price philippinesWebMar 23, 2024 · CUBIST PHARMACEUTICALS INC (NASDAQ:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CUBIST PHARMACEUTICALS … portland cement and sand mix for pool bottomWebApr 6, 2024 · Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) issued its quarterly earnings results on Tuesday, February, 28th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.30. The company had revenue of $61.88 million for the quarter, compared to analysts' expectations of $47.18 million. optical tape storageWebDec 8, 2014 · Cubist Historical Price Data (CBST) - Investing.com Cubist Pharmaceuticals Inc (CBST) NASDAQ Add to Watchlist 101.94 0.00 ( 0.00 %) 31/12 - Closed. Currency in USD ( Disclaimer) Volume: 0... portland cement at ace hardware